INS and type 1 diabetes mellitus: Dr Tejal Desai at UCSF has also received CIRM funding to develop a macroencapsulation technology for T1D based on flexible nanoporous thin films designed to support the long‐term viability and function of allogeneic human ESC‐derived insulin producing beta cells.